Results 181 to 190 of about 7,951,181 (327)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
Las tablas hispano-flamencas de San Pedro de Tejada (Burgos)
, 1974 Basilio Osaba y Ruiz de Erenchun
openalex +1 more source
Epigrafía medieval: tres inscripciones de San Andrés de Arroyo y el rey Alfonso Onceno (1312-1350) [PDF]
, 2003 Ricardo Martínez Ortega
openalex
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas +18 more
wiley +1 more source
L'ippica italiana tra innovazione e tradizione. Il caso delle aree di San Siro a Milano
, 2012 Cristiano Mutti
openalex +1 more source
Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective People with Parkinson's disease (PD) and rapid eye movement (REM) sleep without atonia (RSWA) often have more severe gait disturbances compared to PD without RSWA. The association between the presence and expression of RSWA and the rate of progression of gait impairment in PD is unknown.
Sommer L. Amundsen‐Huffmaster +11 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
United States Department of Health and Human Services. Centers for Disease Control and Prevention +1 more
openalex +1 more source
Academic Affairs Division Newsletter: A Fond Farewell to Provost Junn, January 2014 [PDF]
, 2014 San Jose State University
core +1 more source